Particularly, the analysis of the various mutations showed that they can be classified as founder, shared and unique mutations: parental clones acquire mutations in driver genes, such as APC, KRAS and FBWX7 as founder mutations during tumor development, whereas subclones acquire mutations in PIK3CA mutations as progressor mutations [41]. Here, KRAS is linked to neoplasm.